Intervention

Carboplatin Injection

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 10 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials10
Recruiting5
Common conditions12
Lead sponsors shown7
Advertisement

Clinical trials

10 shown
A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast CancerNCT07544056 · 2026-06-04
RECRUITING
SKB500 Combinations in Patients With Small Cell Lung CancerNCT07296809 · 2026-01-30
RECRUITING
Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q MutationNCT06956001 · 2024-11-19
RECRUITING
A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain MetastasesNCT06970639 · 2024-09-26
RECRUITING
Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion MutationsNCT06514027 · 2024-08-28
RECRUITING
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung CancerNCT07383116 · 2026-01-15
NOT_YET_RECRUITING
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung CancerNCT07360132 · 2026-01-15
NOT_YET_RECRUITING
A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung CancerNCT07009457 · 2025-06-16
ACTIVE_NOT_RECRUITING
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung CancerNCT06786312 · 2025-01-25
NOT_YET_RECRUITING
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLCNCT04363255 · 2020-05-01
UNKNOWN

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

Trial status mix

RECRUITING5
NOT_YET_RECRUITING3
ACTIVE_NOT_RECRUITING1
UNKNOWN1

Phase mix

PHASE25
PHASE35
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.